These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30379223)

  • 1. Lung cancer biopsy: Can diagnosis be changed after immunohistochemistry when the H&E-Based morphology corresponds to a specific tumor subtype?
    Bernardi FDC; Bernardi MDC; Takagaki T; Siqueira SAC; Dolhnikoff M
    Clinics (Sao Paulo); 2018 Oct; 73():e361. PubMed ID: 30379223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Value of Cytokeratin 5/6, p63 and Thyroid Transcription Factor-1 in Adenocarcinoma, Squamous Cell Carcinoma and Non-Small-Cell Lung Cancer of the Lung.
    Argon A; Nart D; Veral A
    Turk Patoloji Derg; 2015; 31(2):81-8. PubMed ID: 25944390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens.
    Rekhtman N; Ang DC; Sima CS; Travis WD; Moreira AL
    Mod Pathol; 2011 Oct; 24(10):1348-59. PubMed ID: 21623384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reevaluation and reclassification of resected lung carcinomas originally diagnosed as squamous cell carcinoma using immunohistochemical analysis.
    Kadota K; Nitadori J; Rekhtman N; Jones DR; Adusumilli PS; Travis WD
    Am J Surg Pathol; 2015 Sep; 39(9):1170-80. PubMed ID: 25871623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6.
    Mukhopadhyay S; Katzenstein AL
    Am J Surg Pathol; 2011 Jan; 35(1):15-25. PubMed ID: 21164283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expressions of Thyroid Transcription Factor-1, Napsin A, p40, p63, CK5/6 and Desmocollin-3 in Non-Small Cell Lung Cancer, as Revealed by Imprint Cytology Using a Malinol-Based Cell-Transfer Technique.
    Kawai T; Tominaga S; Hiroi S; Kameda K; Ogata S; Nakashima H; Ozeki Y; Nakanishi K
    Acta Cytol; 2015; 59(6):457-64. PubMed ID: 26696549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunhistochemistry by means of widely agreed-upon markers (cytokeratins 5/6 and 7, p63, thyroid transcription factor-1, and vimentin) on small biopsies of non-small cell lung cancer effectively parallels the corresponding profiling and eventual diagnoses on surgical specimens.
    Pelosi G; Rossi G; Bianchi F; Maisonneuve P; Galetta D; Sonzogni A; Veronesi G; Spaggiari L; Papotti M; Barbareschi M; Graziano P; Decensi A; Cavazza A; Viale G
    J Thorac Oncol; 2011 Jun; 6(6):1039-49. PubMed ID: 21512408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of immunohistochemistry in the differential diagnosis of non-small cell lung carcinomas on small biopsy samples.
    Stojsic J; Jovanic I; Markovic J; Gajic M
    J BUON; 2013; 18(1):176-87. PubMed ID: 23613404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of immunohistochemical staining p63 and TTF-1 with EGFR and K-ras mutational spectrum and diagnostic reproducibility in non small cell lung carcinoma.
    Thunnissen E; Boers E; Heideman DA; Grünberg K; Kuik DJ; Noorduin A; van Oosterhout M; Pronk D; Seldenrijk C; Sietsma H; Smit EF; van Suylen R; von der Thusen J; Vrugt B; Wiersma A; Witte BI; den Bakker M
    Virchows Arch; 2012 Dec; 461(6):629-38. PubMed ID: 23064619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of classifying poorly differentiated non-small cell lung carcinoma biopsies with commonly used lung carcinoma markers.
    Zachara-Szczakowski S; Verdun T; Churg A
    Hum Pathol; 2015 May; 46(5):776-82. PubMed ID: 25776027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High frequency of coexpression of maspin with p63 and p53 in squamous cell carcinoma but not in adenocarcinoma of the lung.
    Choy B; Findeis-Hosey JJ; Li F; McMahon LA; Yang Q; Xu H
    Int J Clin Exp Pathol; 2013; 6(11):2542-7. PubMed ID: 24228118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subtyping of undifferentiated non-small cell carcinomas in bronchial biopsy specimens.
    Loo PS; Thomas SC; Nicolson MC; Fyfe MN; Kerr KM
    J Thorac Oncol; 2010 Apr; 5(4):442-7. PubMed ID: 20195168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of BRCA1-associated protein 1 (BAP1) expression is rare in non-small cell lung cancer.
    Owen D; Sheffield BS; Ionescu D; Churg A
    Hum Pathol; 2017 Feb; 60():82-85. PubMed ID: 27984124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic utility of fine needle aspiration cytology and core biopsy histopathology with or without immunohistochemical staining in the subtyping of the non-small cell lung carcinomas: Experience from an academic centre in Turkey.
    Bayrak BY; Paksoy N; Vural Ç
    Cytopathology; 2021 May; 32(3):331-337. PubMed ID: 33145811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P16 is a useful supplemental diagnostic marker of pulmonary small cell carcinoma in small biopsies and cytology specimens.
    Švajdler M; Mezencev R; Ondič O; Šašková B; Mukenšnábl P; Michal M
    Ann Diagn Pathol; 2018 Apr; 33():23-29. PubMed ID: 29566943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemistry in the differential diagnostics of primary lung cancer: an investigation within the Southern Swedish Lung Cancer Study.
    Brunnström H; Johansson L; Jirström K; Jönsson M; Jönsson P; Planck M
    Am J Clin Pathol; 2013 Jul; 140(1):37-46. PubMed ID: 23765532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromogenic immunohistochemical quadruplex provides accurate diagnostic differentiation of non-small cell lung cancer.
    Roberts EA; Morrison LE; Behman LJ; Draganova-Tacheva R; O'Neill R; Solomides CC
    Ann Diagn Pathol; 2020 Apr; 45():151454. PubMed ID: 31923744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of p63, TTF-1 and Maspin in Non-Small Cell Lung Carcinoma and Their Effect on the Prognosis and Differential Diagnosis.
    Yaman B; Nart D; Ekren PK; Çok G; Veral A
    Turk Patoloji Derg; 2015; 31(3):163-74. PubMed ID: 26456962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The utility of TTF-1, napsin A, CK5 and p63 staining in the sub-classification of non-small cell carcinoma of the lung.
    van Zyl A; Schubert PT; Koegelenberg CFN
    Cytopathology; 2019 Nov; 30(6):586-591. PubMed ID: 31206846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spindle cell and pleomorphic ("sarcomatoid") carcinomas of the lung: an immunohistochemical analysis of 86 cases.
    Weissferdt A; Kalhor N; Rodriguez Canales J; Fujimoto J; Wistuba II; Moran CA
    Hum Pathol; 2017 Jan; 59():1-9. PubMed ID: 27569293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.